Department of Anatomy, Yonsei University College of Medicine, Seoul, Republic of Korea
Anticancer Res. 2020 Jun;40(6):3039-3047. doi: 10.21873/anticanres.14284.
Over the past few decades, longevity without disease has become an important topic worldwide. However, as life expectancy increases, the number of patients with cancer is also increasing. Tumor progression is related to interactions between tumor cells and mesenchymal stem cells (MSCs) in the tumor microenvironment. MSCs are multipotent stromal cells known to be present in a variety of locations in the body, including bones, cartilage, fat, muscles, and dental pulp. MSCs migrate toward inflamed areas during pathological immune responses. MSCs also migrate toward tumor stroma and participate in tumor progression. MSCs can contribute to tumor progression by interacting with tumor cells via paracrine signaling and differentiate into diverse cell types. This also enables MSCs to make direct contact with tumor cells in tumor stroma. Interactions between tumor cells and MSCs enhance tumorigenic and metastatic potential, in addition to stimulating epithelial to mesenchymal transition. Herein, we reviewed the research associated with the tumor-enhancing role of MSCs in tumor progression, from primary tumor growth to distant tumor metastasis.
在过去的几十年中,无病长寿已成为全球关注的一个重要话题。然而,随着预期寿命的延长,癌症患者的数量也在增加。肿瘤的进展与肿瘤微环境中肿瘤细胞与间充质干细胞(MSCs)之间的相互作用有关。MSCs 是多能基质细胞,已知存在于体内的多种位置,包括骨骼、软骨、脂肪、肌肉和牙髓。MSCs 在病理免疫反应期间向炎症部位迁移。MSCs 还向肿瘤基质迁移并参与肿瘤的进展。MSCs 可以通过旁分泌信号与肿瘤细胞相互作用并分化为多种细胞类型,从而促进肿瘤的进展。这也使 MSCs 能够与肿瘤基质中的肿瘤细胞直接接触。肿瘤细胞与 MSCs 之间的相互作用增强了致瘤性和转移性潜能,同时还刺激了上皮间质转化。在此,我们回顾了与 MSCs 在肿瘤进展中促进肿瘤的作用相关的研究,从原发性肿瘤生长到远处肿瘤转移。